Efficacy of SNX-1012 in the Treatment of Oral Mucositis

Summary

Oral mucositis (OM) is a common and debilitating toxicity induced by many chemotherapy (CT) regimens and by radiation to the head and neck. The purpose of this study is to determine the effectiveness of SNX-1012 in decreasing the duration of Grade 2, 3, or 4 oral mucositis (OM) according to World Health Organization (WHO) criteria.

Timeline

Start

2006-06

Primary completion

2008-05

Completion

2008-07

Drugs

Indications